ERLOTAZ 100MG

Erlotaz 100mg Tablet is an anticancer medication that contains the active ingredient erlotinib. It is prescribed for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. Cancer is characterized by the uncontrolled and abnormal proliferation of cells. This medication is typically administered alongside another anticancer drug, gemcitabine, for patients suffering from metastatic or advanced pancreatic cancers.

Patients should notify their doctor if they use contact lenses, have any intolerance to sugars, a history of eye issues, or clotting disorders, or if they are taking medications for clotting disorders or cholesterol. Erlotaz 100mg Tablet is not advised for adolescents and children under 18 years of age. It is important to avoid taking this medication with food. Effective birth control should be utilized during treatment and for at least two weeks following the final dose.

Patients are strongly advised against smoking while undergoing treatment with Erlotaz 100mg Tablet, as smoking can reduce the concentration of the medication in the bloodstream. It is also recommended to wear protective clothing and apply sunscreen when outdoors. Patients should inform their physician if they experience eye pain, blurred vision, cough, fever, shortness of breath, severe abdominal pain, or persistent diarrhea while using this medication.